
Asian Market Insights: Viva Goods And Two Other Prominent Penny Stocks

Asian markets are attracting investors with promising penny stocks, despite their risks. Notable mentions include Viva Goods, which operates in apparel and footwear with a market cap of HK$3.39 billion, reporting revenues of HK$10.43 billion for 2024 but a net loss of HK$70.41 million. Qinghai Spring Medicinal Resources Technology, valued at CN¥2.49 billion, shows financial improvement with a net income of CN¥8.92 million in Q1 2025. Lecron Industrial Development Group, with a market cap of CN¥4.54 billion, has shifted to profitability, reporting a net income of CN¥5.02 million in Q1 2025. Investors are encouraged to explore these opportunities further.
As global markets navigate a complex landscape, Asian economies remain a focal point for investors seeking diverse opportunities. Penny stocks, often associated with smaller or emerging companies, continue to offer intriguing potential despite their vintage label. By focusing on those with robust financials and clear growth trajectories, these stocks can present hidden gems within the broader market landscape.
Top 10 Penny Stocks In Asia
| Name | Share Price | Market Cap | Rewards & Risks |
| YKGI (Catalist:YK9) | SGD0.099 | SGD42.08M | ✅ 2 ⚠️ 3 View Analysis > |
| Lever Style (SEHK:1346) | HK$1.14 | HK$719.28M | ✅ 4 ⚠️ 2 View Analysis > |
| Ever Sunshine Services Group (SEHK:1995) | HK$1.89 | HK$3.27B | ✅ 5 ⚠️ 1 View Analysis > |
| TK Group (Holdings) (SEHK:2283) | HK$2.06 | HK$1.72B | ✅ 4 ⚠️ 1 View Analysis > |
| CNMC Goldmine Holdings (Catalist:5TP) | SGD0.44 | SGD178.33M | ✅ 3 ⚠️ 3 View Analysis > |
| Goodbaby International Holdings (SEHK:1086) | HK$1.17 | HK$1.95B | ✅ 4 ⚠️ 2 View Analysis > |
| Yangzijiang Shipbuilding (Holdings) (SGX:BS6) | SGD2.29 | SGD9.01B | ✅ 5 ⚠️ 0 View Analysis > |
| Beng Kuang Marine (SGX:BEZ) | SGD0.179 | SGD35.66M | ✅ 4 ⚠️ 3 View Analysis > |
| BRC Asia (SGX:BEC) | SGD3.13 | SGD858.72M | ✅ 3 ⚠️ 1 View Analysis > |
| Bosideng International Holdings (SEHK:3998) | HK$4.39 | HK$50.29B | ✅ 4 ⚠️ 1 View Analysis > |
Click here to see the full list of 1,153 stocks from our Asian Penny Stocks screener.
Let's explore several standout options from the results in the screener.
Viva Goods (SEHK:933)
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Viva Goods Company Limited is an investment holding company that supplies apparel and footwear across various regions including the United Kingdom, the Republic of Ireland, the United States, China, Asia, Europe, the Middle East, and Africa with a market cap of HK$3.39 billion.
Operations: The company generates revenue through two main segments: Sports Experience, contributing HK$559.30 million, and Multi-Brand Apparel and Footwear, which accounts for HK$9.87 billion.
Market Cap: HK$3.39B
Viva Goods Company Limited, with a market cap of HK$3.39 billion, operates in the apparel and footwear sectors across various regions. The company reported revenues of HK$10.43 billion for 2024 but remains unprofitable with a net loss of HK$70.41 million, though this is an improvement from the previous year. Recent share repurchase announcements could enhance shareholder value by increasing net asset value per share and earnings per share. Despite its losses, Viva Goods has a strong cash position exceeding its debt and covers both short-term and long-term liabilities effectively with assets totaling HK$5 billion against liabilities of HK$3.5 billion short-term and HK$2 billion long-term.
- Click here and access our complete financial health analysis report to understand the dynamics of Viva Goods.
- Gain insights into Viva Goods' past trends and performance with our report on the company's historical track record.
Qinghai Spring Medicinal Resources Technology (SHSE:600381)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Qinghai Spring Medicinal Resources Technology Co., Ltd. operates in the medicinal resources sector and has a market cap of approximately CN¥2.49 billion.
Operations: Qinghai Spring Medicinal Resources Technology Co., Ltd. has not reported any specific revenue segments.
Market Cap: CN¥2.49B
Qinghai Spring Medicinal Resources Technology, with a market cap of CN¥2.49 billion, shows signs of financial improvement despite its unprofitable status over recent years. The company reported a net income of CN¥8.92 million for Q1 2025, contrasting with a loss the previous year, and annual revenue growth from CN¥213.88 million to CN¥270.26 million in 2024. Its strong cash position covers both short-term liabilities (CN¥70.9M) and long-term liabilities (CN¥2.9M), while remaining debt-free enhances financial stability amidst volatility in earnings and negative return on equity (-15.54%). Management's experience further supports potential operational resilience.
- Jump into the full analysis health report here for a deeper understanding of Qinghai Spring Medicinal Resources Technology.
- Review our historical performance report to gain insights into Qinghai Spring Medicinal Resources Technology's track record.
Lecron Industrial Development Group (SZSE:300343)
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Lecron Industrial Development Group Co., Ltd. operates in the industrial development sector and has a market cap of CN¥4.54 billion.
Operations: Lecron Industrial Development Group Co., Ltd. has not reported any specific revenue segments.
Market Cap: CN¥4.54B
Lecron Industrial Development Group's recent financial performance indicates a shift to profitability, with Q1 2025 net income at CN¥5.02 million compared to a loss the previous year. Despite this positive turn, the company faces challenges like low return on equity (2.1%) and negative operating cash flow, which impacts debt coverage. However, its short-term assets of CN¥1.3 billion significantly exceed liabilities, providing some financial cushion. The company has also initiated a share buyback program worth up to CN¥100 million to support equity incentives, while its experienced management team offers potential stability amidst high stock volatility.
- Dive into the specifics of Lecron Industrial Development Group here with our thorough balance sheet health report.
- Assess Lecron Industrial Development Group's previous results with our detailed historical performance reports.
Make It Happen
- Click through to start exploring the rest of the 1,150 Asian Penny Stocks now.
- Ready To Venture Into Other Investment Styles? Explore 22 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

